Schiff bases complexed with iron and their relation with the life cycle and infection by Schistosoma mansoni

Introduction The trematode Schistosoma mansoni causes schistosomiasis, and this parasite’s life cycle depends on the mollusk Biomphalaria glabrata. The most effective treatment for infected people is administering a single dose of Praziquantel. However, there are naturally resistant to treatment. This work has developed, considering this parasite’s complex life cycle. Methods The synthetics compound were evaluated: i) during the infection of B. glabrata, ii) during the infection of BALB/c mice, and iii) during the treatment of mice infected with S. mansoni. Results and Discussion For the first objective, snails infected with miracidia treated with compounds C1 and C3 at concentrations of 25% IC50 and 50% IC50, after 80 days of infection, released fewer cercariae than the infected group without treatment. For the second objective, compounds C1 and C3 did not show significant results in the infected group without treatment. For the third objective, the mice treated with C3 and C1 reduced the global and differential cell count. The results suggest that although the evaluated compounds do not present schistosomicidal properties when placed in cercariae suspension, they can stimulate an immune reaction in snails and decrease mice’s inflammatory response. In general, we can conclude that compound C1 and C3 has an anti-schistosomicidal effect both in the larval phase (miracidia) and in the adult form of the parasite.

[1]  T. Silva,et al.  Schistosomiasis Mansoni-Recruited Eosinophils: An Overview in the Granuloma Context , 2022, Microorganisms.

[2]  P. Mishra,et al.  Schiff base metal complex as a potential therapeutic drug in medical science: A critical review , 2021, BIBECHANA.

[3]  H. Helmby,et al.  Granuloma formation and tissue pathology in Schistosoma japonicum versus Schistosoma mansoni infections , 2020, Parasite immunology.

[4]  M. Youssef,et al.  In vivo studies of the effect of PPQ-6, a quinoline-based agent against Schistosoma mansoni in mice. , 2020, Experimental parasitology.

[5]  I. Rabinowitch,et al.  Oral Administration of Artemisone for the Treatment of Schistosomiasis: Formulation Challenges and In Vivo Efficacy , 2020, Pharmaceutics.

[6]  Stephanie R. Bollmann,et al.  Neither heat pulse, nor multigenerational exposure to a modest increase in water temperature, alters the susceptibility of Guadeloupean Biomphalaria glabrata to Schistosoma mansoni infection , 2020, PeerJ.

[7]  M. Berriman,et al.  Schistosoma mansoni Eggs Modulate the Timing of Granuloma Formation to Promote Transmission , 2020, bioRxiv.

[8]  D. F. Buccini,et al.  Synthesis and Biological Activities of a Nitro-Shiff Base Compound as a Potential Anti-Inflammatory Agent. , 2020, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[9]  P. Corstjens,et al.  A controlled human Schistosoma mansoni infection model to advance novel drugs, vaccines and diagnostics , 2020, Nature Medicine.

[10]  Renan Vinícius de Araújo,et al.  Searching drugs for Chagas disease, leishmaniasis and schistosomiasis: a brief review. , 2020, International journal of antimicrobial agents.

[11]  J. de Moraes,et al.  Antiparasitic activity of piplartine (piperlongumine) in a mouse model of schistosomiasis. , 2020, Acta tropica.

[12]  F. J. Cabral,et al.  Molluscicidal and cercaricidal activities of curcumin on Biomphalaria glabrata and Schistosoma mansoni cercariae Molluscicidal and cercaricidal activities of curcumin. , 2020, Pest management science.

[13]  M. M. Mourão,et al.  Biomphalaria glabrata immunity: Post-genome advances , 2019, Developmental and comparative immunology.

[14]  Martin L. Nelwan Schistosomiasis: Life Cycle, Diagnosis, and Control , 2019, Current therapeutic research, clinical and experimental.

[15]  L. Montresor,et al.  Compatibility Polymorphism Based on Long-Term Host-Parasite Relationships: Cross Talking Between Biomphalaria glabrata and the Trematode Schistosoma mansoni From Endemic Areas in Brazil , 2019, Front. Immunol..

[16]  J. Keiser,et al.  Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni , 2019, Nature Protocols.

[17]  G. Gasser,et al.  Metal Compounds against Neglected Tropical Diseases. , 2018, Chemical reviews.

[18]  A. Sykuła,et al.  Schiff Bases as Important Class of Pharmacological Agents , 2018 .

[19]  B. Everts,et al.  Early Induction of Human Regulatory Dermal Antigen Presenting Cells by Skin-Penetrating Schistosoma Mansoni Cercariae , 2018, Front. Immunol..

[20]  P. Fallon,et al.  Schistosoma “Eggs-Iting” the Host: Granuloma Formation and Egg Excretion , 2018, Front. Immunol..

[21]  R. Sarhan,et al.  The potential effects of silver and gold nanoparticles as molluscicides and cercaricides on Schistosoma mansoni , 2018, Parasitology Research.

[22]  A. M. Azzam,et al.  IN VITRO EFFECTS OF IRON NANOPARTICLES ON SCHISTOSOMA MANSONI ADULT WORMS AND ITS INTERMEDIATE HOST SNAIL, BIOMPHALARIA ALEXANDRINA , 2018, Journal of the Egyptian Society of Parasitology.

[23]  Z. Bisoffi,et al.  Schistosomiasis in immigrants, refugees and travellers in an Italian referral centre for tropical diseases , 2018, Infectious Diseases of Poverty.

[24]  T. S. St. Pierre,et al.  Study of diagnostic accuracy of Helmintex, Kato-Katz, and POC-CCA methods for diagnosing intestinal schistosomiasis in Candeal, a low intensity transmission area in northeastern Brazil , 2018, PLoS neglected tropical diseases.

[25]  A. Kursunlu,et al.  Fe (III), Co(II), Ni(II), Cu(II) and Zn(II) complexes of schiff bases based-on glycine and phenylalanine: Synthesis, magnetic/thermal properties and antimicrobial activity , 2018 .

[26]  Saima Akhter,et al.  SYNTHESIS OF SCHIFF BASE METAL COMPLEXES: A CONCISE REVIEW , 2017 .

[27]  L. Rolim,et al.  Schistosomiasis: Drugs used and treatment strategies. , 2017, Acta tropica.

[28]  J. de Moraes,et al.  Antiparasitic activity of nerolidol in a mouse model of schistosomiasis. , 2017, International journal of antimicrobial agents.

[29]  R. Dorostkar,et al.  Anthelmintic effects of zinc oxide and iron oxide nanoparticles against Toxocara vitulorum , 2017, International Nano Letters.

[30]  A. Hameed,et al.  Schiff bases in medicinal chemistry: a patent review (2010-2015) , 2017, Expert opinion on therapeutic patents.

[31]  Laiza Gabriela Gavioli Coelho Bases de Schiff como potenciais agentes leishmanicidas contra Leishmania chagasi in vitro , 2016 .

[32]  Abeer A. Alhadi,et al.  Rational Design and Synthesis of New, High Efficiency, Multipotent Schiff Base-1,2,4-triazole Antioxidants Bearing Butylated Hydroxytoluene Moieties , 2016, Molecules.

[33]  L. Faccioli,et al.  Anti-Inflammatory Properties of Menthol and Menthone in Schistosoma mansoni Infection , 2016, Front. Pharmacol..

[34]  E. Carrilho,et al.  Morphological Characteristics of Schistosoma mansoni PZQ-Resistant and -Susceptible Strains Are Different in Presence of Praziquantel , 2016, Front. Microbiol..

[35]  I. M. Mohamed,et al.  A review on versatile applications of transition metal complexes incorporating Schiff bases , 2015, Beni-Suef University Journal of Basic and Applied Sciences.

[36]  张静,et al.  Banana Ovate family protein MaOFP1 and MADS-box protein MuMADS1 antagonistically regulated banana fruit ripening , 2015 .

[37]  P. Fallon,et al.  The Schistosoma Granuloma: Friend or Foe? , 2013, Front. Immunol..

[38]  D. Gelain,et al.  Schistosoma mansoni infection causes oxidative stress and alters receptor for advanced glycation endproduct (RAGE) and tau levels in multiple organs in mice. , 2013, International journal for parasitology.

[39]  M. Rudrapal,et al.  Chemistry and Biological Importance of Heterocyclic Schiff's Bases , 2013 .

[40]  A. C. A. Mattos,et al.  Interaction of Schistosoma mansoni Sporocysts and Hemocytes of Biomphalaria , 2012, Journal of parasitology research.

[41]  Anren Hu,et al.  Synthesis, characterization and biological evaluation of mononuclear Co(II), Ni(II), Cu(II) and Pd(II) complexes with new N2O2 Schiff base ligands. , 2011, Chemical & pharmaceutical bulletin.

[42]  B. Dede,et al.  Novel homo- and hetero-nuclear copper(II) complexes of tetradentate Schiff bases: synthesis, characterization, solvent-extraction and catalase-like activity studies. , 2009, Journal of hazardous materials.

[43]  Pengcheng Li,et al.  Antifungal properties of Schiff bases of chitosan, N-substituted chitosan and quaternized chitosan. , 2007, Carbohydrate research.

[44]  A. Marsaioli,et al.  Antimycobacterial and cytotoxicity activity of synthetic and natural compounds , 2007 .

[45]  E. Pearce,et al.  Association of Type 2 Cytokines with Hepatic Fibrosis in Human Schistosoma mansoni Infection , 2004, Infection and Immunity.

[46]  F. Trottein,et al.  Schistosomes in the skin: a balance between immune priming and regulation. , 2004, Trends in parasitology.

[47]  S. Kumkate,et al.  Interleukin-12 p40 Secretion by Cutaneous CD11c+ and F4/80+ Cells Is a Major Feature of the Innate Immune Response in Mice That Develop Th1-Mediated Protective Immunity to Schistosomamansoni , 2003, Infection and Immunity.

[48]  Naftale Katz,et al.  Esquistossomose, xistosa, barriga d'água , 2003 .

[49]  G. Robino,et al.  Oxidative stress-related molecules and liver fibrosis. , 2001, Journal of hepatology.

[50]  R. C. Bender,et al.  KILLING OF SCHISTOSOMA MANSONI SPOROCYSTS BY HEMOCYTES FROM RESISTANT BIOMPHALARIA GLABRATA: ROLE OF REACTIVE OXYGEN SPECIES , 2001, The Journal of parasitology.

[51]  H. Dessein,et al.  Development of eosinophil peroxidase activity and concomitant alteration of the antioxidant defenses in the liver of mice infected with Schistosoma mansoni. , 1999, Journal of hepatology.

[52]  A. A. Abdel Hadi,et al.  Study of the efficacy of the new antischistosomal drug 10-[2-(diethylamino)ethyl]-9-acridanone-(thiazolidin-2-ylidene) hydrazone against an Egyptian strain of S. mansoni in mice. , 1997, Arzneimittel-Forschung.

[53]  P. Coelho,et al.  Activity of 9-acridanone-hydrazone drugs detected at the pre-postural phase, in the experimental schistosomiasis mansoni. , 1995, Memorias do Instituto Oswaldo Cruz.

[54]  E. M. Zanotti-Magalhães,et al.  [Relationship between the pathogenicity of Schistosoma mansoni in mice and the susceptibility of the mollusk vector. II. Number of eggs in feces and number and size of granuloma in visceras]. , 1993, Revista de saude publica.

[55]  A. Tartakoff,et al.  Glycocalyx of bodies versus tails of Schistosoma mansoni cercariae. Lectin-binding, size, charge, and electron microscopic characterization. , 1991, The Journal of biological chemistry.

[56]  E. Loker,et al.  Immune mechanisms in trematode-snail interactions. , 1990, Parasitology today.

[57]  P. Coulson,et al.  Antigen localization and the induction of resistance in mice vaccinated with irradiated cercariae of Schistosoma mansoni , 1988, Parasitology.

[58]  J. Dalton,et al.  Schistosoma mansoni: immunogenic glycoproteins of the cercarial glycocalyx. , 1987, Experimental parasitology.

[59]  J. Caulfield,et al.  Cercarial glycocalyx of Schistosoma mansoni activates human complement , 1986, Infection and immunity.

[60]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[61]  D. McLaren,et al.  Histopathological and ultrastructural studies of cutaneous reactions elicited in naive and chronically infected mice by invading schistosomula of Schistosoma mansoni. , 1984, International journal for parasitology.

[62]  M. Stirewált Schistosoma mansoni: cercaria to schistosomule. , 1974, Advances in parasitology.

[63]  N Katz,et al.  A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. , 1972, Revista do Instituto de Medicina Tropical de Sao Paulo.

[64]  S. R. Smithers,et al.  The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms , 1965, Parasitology.

[65]  M. Stirewált,et al.  An efficient method for exposure of mice to cercariae of Schistosoma mansoni. , 1952, The Journal of parasitology.

[66]  C. Aring,et al.  A CRITICAL REVIEW , 1939, Journal of neurology and psychiatry.

[67]  H. Schiff Mittheilungen aus dem Universitätslaboratorium in Pisa: Eine neue Reihe organischer Basen , 1864 .